Cargando…
TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is e...
Autores principales: | You, Yun-Fan, Chen, Man, Tang, Yue, Yu, Wen-Xiang, Pang, Xiao-Wei, Chu, Yun-Hui, Zhang, Hang, Shang, Ke, Deng, Gang, Zhou, Luo-Qi, Yang, Sheng, Wang, Wei, Xiao, Jun, Tian, Dai-Shi, Qin, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069075/ https://www.ncbi.nlm.nih.gov/pubmed/37013543 http://dx.doi.org/10.1186/s12974-023-02772-3 |
Ejemplares similares
-
Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders
por: Li, Jinghong, et al.
Publicado: (2022) -
Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
por: Deeb, Khaled, et al.
Publicado: (2019) -
Jaw clonus in neuromyelitis optica spectrum disorder with subsequent osmotic demyelination syndrome
por: Ghosh, Ritwik, et al.
Publicado: (2020) -
Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)